• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mapping the binding region on the low density lipoprotein receptor for blood coagulation factor VIII.绘制凝血因子 VIII 与低密度脂蛋白受体结合区域的图谱。
J Biol Chem. 2013 Jul 26;288(30):22033-41. doi: 10.1074/jbc.M113.468108. Epub 2013 Jun 10.
2
Cluster III of low-density lipoprotein receptor-related protein 1 binds activated blood coagulation factor VIII.低密度脂蛋白受体相关蛋白1的III型簇结合活化的凝血因子VIII。
Biochemistry. 2015 Jan 20;54(2):481-9. doi: 10.1021/bi5011688. Epub 2014 Dec 23.
3
Functional duplication of ligand-binding domains within low-density lipoprotein receptor-related protein for interaction with receptor associated protein, alpha2-macroglobulin, factor IXa and factor VIII.低密度脂蛋白受体相关蛋白内配体结合结构域的功能重复,用于与受体相关蛋白、α2-巨球蛋白、凝血因子IXa和凝血因子VIII相互作用。
Biochim Biophys Acta. 2007 Jun;1774(6):714-22. doi: 10.1016/j.bbapap.2007.04.003. Epub 2007 Apr 14.
4
Molecular chaperone RAP interacts with LRP1 in a dynamic bivalent mode and enhances folding of ligand-binding regions of other LDLR family receptors.分子伴侣 RAP 以动态二价模式与 LRP1 相互作用,并增强其他 LDLR 家族受体配体结合区域的折叠。
J Biol Chem. 2021 Jul;297(1):100842. doi: 10.1016/j.jbc.2021.100842. Epub 2021 May 29.
5
LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo.低密度脂蛋白受体与低密度脂蛋白受体相关蛋白在体内协同调节凝血因子 VIII 的血浆水平。
Blood. 2005 Aug 1;106(3):906-12. doi: 10.1182/blood-2004-11-4230. Epub 2005 Apr 19.
6
Localization of the low-density lipoprotein receptor-related protein regions involved in binding to the A2 domain of coagulation factor VIII.参与与凝血因子VIII的A2结构域结合的低密度脂蛋白受体相关蛋白区域的定位。
Thromb Haemost. 2007 Dec;98(6):1170-81.
7
The second and fourth cluster of class A cysteine-rich repeats of the low density lipoprotein receptor-related protein share ligand-binding properties.低密度脂蛋白受体相关蛋白富含半胱氨酸重复序列的A类中,第二个和第四个簇具有共同的配体结合特性。
J Biol Chem. 1999 Oct 29;274(44):31305-11. doi: 10.1074/jbc.274.44.31305.
8
Structure of an LDLR-RAP complex reveals a general mode for ligand recognition by lipoprotein receptors.低密度脂蛋白受体-受体相关蛋白复合物的结构揭示了脂蛋白受体识别配体的一般模式。
Mol Cell. 2006 Apr 21;22(2):277-83. doi: 10.1016/j.molcel.2006.02.021.
9
Molecular analysis of ligand binding to the second cluster of complement-type repeats of the low density lipoprotein receptor-related protein. Evidence for an allosteric component in receptor-associated protein-mediated inhibition of ligand binding.低密度脂蛋白受体相关蛋白补体样重复序列第二簇与配体结合的分子分析。受体相关蛋白介导的配体结合抑制中变构成分的证据。
J Biol Chem. 1997 May 23;272(21):13608-13. doi: 10.1074/jbc.272.21.13608.
10
Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein.低密度脂蛋白受体相关蛋白中尿激酶型纤溶酶原激活物-纤溶酶原激活物抑制剂-1复合物双结构域结合位点的分析
Biochem J. 2001 Jul 1;357(Pt 1):289-96. doi: 10.1042/0264-6021:3570289.

引用本文的文献

1
Challenges in lentiviral vector production: retro-transduction of producer cell lines.慢病毒载体生产中的挑战:生产细胞系的逆转导。
Front Bioeng Biotechnol. 2025 May 29;13:1569298. doi: 10.3389/fbioe.2025.1569298. eCollection 2025.
2
Plasma Clearance of Coagulation Factor VIII and Extension of Its Half-Life for the Therapy of Hemophilia A: A Critical Review of the Current State of Research and Practice.血浆清除凝血因子 VIII 及其半衰期延长在血友病 A 治疗中的应用:当前研究和实践状况的批判性综述。
Int J Mol Sci. 2023 May 11;24(10):8584. doi: 10.3390/ijms24108584.
3
Isolated Variable Domains of an Antibody Can Assemble on Blood Coagulation Factor VIII into a Functional Fv-like Complex.抗体的分离可变结构域可在凝血因子 VIII 上组装成功能性 Fv 样复合物。
Int J Mol Sci. 2022 Jul 23;23(15):8134. doi: 10.3390/ijms23158134.
4
Characterization of interaction between blood coagulation factor VIII and LRP1 suggests dynamic binding by alternating complex contacts.凝血因子 VIII 与 LRP1 相互作用的特性表明通过交替的复合接触进行动态结合。
J Thromb Haemost. 2022 Oct;20(10):2255-2269. doi: 10.1111/jth.15817. Epub 2022 Aug 4.
5
Hypercholesterolemia induced cerebral small vessel disease.高胆固醇血症诱发脑小血管病。
PLoS One. 2017 Aug 10;12(8):e0182822. doi: 10.1371/journal.pone.0182822. eCollection 2017.
6
Disruption of ldlr causes increased LDL-c and vascular lipid accumulation in a zebrafish model of hypercholesterolemia.在高胆固醇血症斑马鱼模型中,低密度脂蛋白受体(Ldlr)的破坏会导致低密度脂蛋白胆固醇(LDL-c)升高和血管脂质蓄积。
J Lipid Res. 2014 Nov;55(11):2242-53. doi: 10.1194/jlr.M046540. Epub 2014 Sep 8.

本文引用的文献

1
Insect cell-based expression and characterization of a single-chain variable antibody fragment directed against blood coagulation factor VIII.基于昆虫细胞的抗凝血因子VIII单链可变抗体片段的表达与特性分析
Protein Expr Purif. 2013 Apr;88(2):201-6. doi: 10.1016/j.pep.2012.12.008. Epub 2013 Jan 7.
2
In vitro characterization of recombinant factor VIII concentrates reveals significant differences in protein content, activity and thrombin activation profile.在体研究显示,重组凝血因子 VIII 制剂在蛋白含量、活性和凝血酶激活谱方面存在显著差异。
Haemophilia. 2013 May;19(3):392-8. doi: 10.1111/hae.12076. Epub 2012 Dec 18.
3
Endocytic receptors in the renal proximal tubule.肾近端小管内的内吞受体。
Physiology (Bethesda). 2012 Aug;27(4):223-36. doi: 10.1152/physiol.00022.2012.
4
The fraction of recombinant factor VIII:Ag unable to bind von Willebrand factor has no FVIII coagulant activity: studies in vitro.无法与血管性血友病因子结合的重组因子 VIII:Ag 片段没有 FVIII 凝血活性:体外研究。
Haemophilia. 2012 Nov;18(6):917-25. doi: 10.1111/j.1365-2516.2012.02861.x. Epub 2012 Jun 4.
5
The structure, dynamics, and binding of the LA45 module pair of the low-density lipoprotein receptor suggest an important role for LA4 in ligand release.低密度脂蛋白受体的 LA45 模块对的结构、动力学和结合表明 LA4 在配体释放中起重要作用。
Biochemistry. 2011 Dec 27;50(51):11001-8. doi: 10.1021/bi2014486. Epub 2011 Nov 29.
6
C1 domain residues Lys 2092 and Phe 2093 are of major importance for the endocytic uptake of coagulation factor VIII.C1 结构域残基 Lys2092 和 Phe2093 对凝血因子 VIII 的内吞摄取至关重要。
Int J Biochem Cell Biol. 2011 Aug;43(8):1114-21. doi: 10.1016/j.biocel.2011.03.014. Epub 2011 Apr 8.
7
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile.载脂蛋白 LDLR 基因多态性可能通过调节凝血因子 VIII 活性,并独立于血脂谱,与冠心病相关。
Blood. 2010 Dec 16;116(25):5688-97. doi: 10.1182/blood-2010-03-277079. Epub 2010 Sep 1.
8
Functional characteristics of N8, a new recombinant FVIII.新型 FVIII 重组体 N8 的功能特征。
Haemophilia. 2010 Nov;16(6):878-87. doi: 10.1111/j.1365-2516.2010.02333.x.
9
Structural basis for specific recognition of reelin by its receptors.Reelin 与其受体特异性识别的结构基础。
Structure. 2010 Mar 10;18(3):320-31. doi: 10.1016/j.str.2010.01.010.
10
Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity.凝血因子VIII C1结构域的赖氨酸2092和苯丙氨酸2093残基有助于膜结合和辅因子活性。
Blood. 2009 Oct 29;114(18):3938-46. doi: 10.1182/blood-2009-01-197707. Epub 2009 Aug 17.

绘制凝血因子 VIII 与低密度脂蛋白受体结合区域的图谱。

Mapping the binding region on the low density lipoprotein receptor for blood coagulation factor VIII.

机构信息

Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20852, USA.

出版信息

J Biol Chem. 2013 Jul 26;288(30):22033-41. doi: 10.1074/jbc.M113.468108. Epub 2013 Jun 10.

DOI:10.1074/jbc.M113.468108
PMID:23754288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3724656/
Abstract

Low density lipoprotein receptor (LDLR) was shown to mediate clearance of blood coagulation factor VIII (FVIII) from the circulation. To elucidate the mechanism of interaction of LDLR and FVIII, our objective was to identify the region of the receptor necessary for binding FVIII. Using surface plasmon resonance, we found that LDLR exodomain and its cluster of complement-type repeats (CRs) bind FVIII in the same mode. This indicated that the LDLR site for FVIII is located within the LDLR cluster. Similar results were obtained for another ligand of LDLR, α-2-macroglobulin receptor-associated protein (RAP), a common ligand of receptors from the LDLR family. We further generated a set of recombinant fragments of the LDLR cluster and assessed their structural integrity by binding to RAP and by circular dichroism. A number of fragments overlapping CR.2-5 of the cluster were positive for binding RAP and FVIII. The specificity of these interactions was tested by site-directed mutagenesis of conserved tryptophans within the LDLR fragments. For FVIII, the specificity was also tested using a single-chain variable antibody fragment directed against the FVIII light chain as a competitor. Both cases resulted in decreased binding, thus confirming its specificity. The mutagenic study also showed an importance of the conserved tryptophans in LDLR for both ligands, and the competitive binding results showed an involvement of the light chain of FVIII in its interaction with LDLR. In conclusion, the region of CR.2-5 of LDLR was defined as the binding site for FVIII and RAP.

摘要

低密度脂蛋白受体(LDLR)被证明可以介导清除循环中的凝血因子 VIII(FVIII)。为了阐明 LDLR 和 FVIII 相互作用的机制,我们的目标是确定受体结合 FVIII 所必需的区域。通过表面等离子体共振,我们发现 LDLR 外显子及其补体型重复簇(CRs)以相同的模式结合 FVIII。这表明 LDLR 与 FVIII 的结合部位位于 LDLR 簇内。对于 LDLR 的另一种配体α-2-巨球蛋白受体相关蛋白(RAP),也得到了类似的结果,RAP 是 LDLR 家族受体的共同配体。我们进一步生成了一组 LDLR 簇的重组片段,并通过与 RAP 和圆二色性结合来评估其结构完整性。一些与簇的 CR.2-5 重叠的片段与 RAP 和 FVIII 结合呈阳性。通过 LDLR 片段中保守色氨酸的定点突变测试了这些相互作用的特异性。对于 FVIII,还使用针对 FVIII 轻链的单链可变抗体片段作为竞争物进行了特异性测试。这两种情况都导致结合减少,从而证实了其特异性。诱变研究还表明,LDLR 中的保守色氨酸对于两种配体都很重要,竞争结合结果表明 FVIII 的轻链参与了其与 LDLR 的相互作用。总之,CR.2-5 区域被定义为 LDLR 与 FVIII 和 RAP 的结合位点。